ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 21 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Natural Capsules Investor Presentation: Key Takeaways

NCL reported Q1FY27 revenue of ₹48.71 Cr (+8% Y-o-Y) with EBITDA at ₹1.12 Cr. Strategy focuses on scaling steroidal API volumes and HPMC line conversions to optimize capacity.

Highlights
Revenue growth8% Y-o-Y
MarginsEBITDA margin at 2.30% (+159 BPS Y-o-Y); gelatine capsules delivering healthy margins.
Demand visibilityFirm demand in capsules; erratic US HPMC environment.
Management confidenceConfident in sustained profitability for capsules; improved visibility for Q2FY27.

Growth

Revenue grew 8% Y-o-Y to ₹48.71 Cr; PAT stood at a loss of ₹5.74 Cr. EBITDA rose 251% Y-o-Y.

Outlook

Converting two HPMC lines to gelatine; expecting first backward-integrated prednisolone batch by September 2026. PLI incentive of ~₹67 Cr over 6 years.

Risks

US HPMC demand remains erratic; geopolitical uncertainty and currency fluctuations impacting African export volumes via merchant exporters.

Last quarter's promises, checked

Delivered

  • Guided Q4FY26 API sales start → Delivered Q4FY26 commencement (= BEAT)
  • Guided HPMC line ready for qualification → Delivered ready for double zero (= BEAT)

Partly delivered

  • Guided WHO GMP audit Q2FY27 → Delivered application initiated/audit expected (= PARTIAL)
  • Guided Prednisolone commercial scale-up Q2/Q3 → Delivered synthesis at gram-scale (= PARTIAL)

Missed

  • Guided FY27 HPMC revenue ₹20 Cr → Delivered Q1FY27 erratic demand (= MISS)
  • Guided FY27 API revenue ₹70 Cr → Delivered Q1FY27 mixed picture/lower run-rate (= MISS)
Source

Investor Presentation filed with BSE, NSE: NATCAPSUQ. Summary written with AI assistance from the document.

Read the document ↗

Natural Capsules Ltd: key numbers

Share price
₹126.19
Market cap
₹131.4 Cr
Revenue (annual)
₹187.2 Cr
Net profit (annual)
₹-24.66 Cr
P/E (TTM)
-8.3×Sector 49.0×
Promoter holding
50.92%+0.00% QoQ
FII holding
0.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Natural Capsules Ltd

All →